Synthesis and preliminary evaluation of (S)-[11C]-exaprolol, a novel beta-adrenoceptor ligand for PET

Neurochemistry International
A van WaardeP H Elsinga

Abstract

Positron-emitting beta-adrenoceptor ligands for the CNS could allow determination of changes in beta-adrenoceptor availability after treatment of patients with norepinephrine reuptake inhibitors or tricyclic antidepressants, and differential diagnosis between multiple sclerosis and other brain disorders in an early stage of the disease. No ligands suitable for this purpose are available for human use. In order to prepare a tracer for human studies, we labeled the biologically active enantiomer of the beta-blocker exaprolol with (11)C. Exaprolol has the appropriate lipophilicity (log P + 1.6) for entry of the CNS and is claimed to be a very potent beta-adrenoceptor antagonist. (S)-Desisopropyl-exaprolol was synthesized by reaction of 2-hexylphenol with (S)-glycidyl-nosylate followed by ring opening using ammonia gas. The desisopropyl precursor was reacted with (11)C-acetone in methanol to produce (S)-[(11)C]-exaprolol. Radiochemical purification was performed with RP-HPLC and was followed by Sep-Pak formulation. The labeled product was i.v. injected into male Wistar rats. Brain images were acquired using a microPET Focus 220 and the biodistribution of (11)C was assessed. The radiochemical yield of (S)-[(11)C]-exaprolol was 7% wi...Continue Reading

References

Jul 20, 1979·Naunyn-Schmiedeberg's Archives of Pharmacology·S R NahorskiE L Rugg
May 1, 1976·British Journal of Pharmacology·C T Dollery, A F Junod
Jul 1, 1992·International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology·M S BerridgeJ M Vesselle
Sep 1, 1984·The Journal of Pharmacy and Pharmacology·B HughesJ R Parratt
May 1, 1981·British Journal of Pharmacology·B A Hemsworth, J A Street
Nov 24, 1999·Neurology·Jacques De KeyserC Streetland
Jul 19, 2000·Neuroscience Letters·Esther ZeinstraJacques De Keyser
Sep 30, 2000·International Journal of Pharmaceutics·Rosa Maria MorescoFerruccio Fazio
Mar 10, 2004·Neurobiology of Disease·Jacques De KeyserNadine Wilczak
Apr 23, 2004·Trends in Pharmacological Sciences·Jacques De KeyserNadine Wilczak
May 12, 2004·Current Pharmaceutical Design·A van WaardeP H Elsinga

Citations

Dec 19, 2014·The International Journal of Neuropsychopharmacology·Sjoerd J FinnemaC Halldin
Sep 10, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Santosh Reddy AlluriKun-Eek Kil

Related Concepts

Exaprolol sulfate
Adrenergic beta-Antagonists
Brain
Propanolamines
Beta-adrenergic receptor
Drug or Chemical Tissue Distribution
Rats, Wistar
Radiopharmaceuticals
Positron-Emission Tomography

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.